[Preventive administration of immunoglobulins in bronchial carcinoma patients treated with aggressive chemotherapy].
D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000517:prevention & control; D002283:Carcinoma, Bronchogenic / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000378:metabolism; D007136:Immunoglobulins / Q000378:metabolism; D007700:Kinetics; D008175:Lung Neoplasms / Q000628:therapy*; D008213:Lymphocyte Activation / Q000187:drug effects; D008934:Mitogens
D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D007136:Immunoglobulins; D008934:Mitogens
Prophylaktische Gabe von Immunglobulinen bei aggressiv chemotherapierten Patienten mit Bronchialkarzinomen.